{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T15:29:29Z","timestamp":1791127769511,"version":"4.1.0"},"reference-count":95,"publisher":"Japanese Association for Laboratory Animal Science","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp. Anim."],"published-print":{"date-parts":[[2014]]},"DOI":"10.1538\/expanim.63.121","type":"journal-article","created":{"date-parts":[[2014,4,25]],"date-time":"2014-04-25T23:09:20Z","timestamp":1398467360000},"page":"121-132","source":"Crossref","is-referenced-by-count":80,"title":["Diabetic Complications in Obese Type 2 Diabetic Rat Models"],"prefix":"10.1538","volume":"63","author":[{"given":"Yoshiaki","family":"Katsuda","sequence":"first","affiliation":[{"name":"Japan Tobacco Inc., Central Pharmaceutical Research Institute, 1\u20131 Murasaki-cho, Takatsuki, Osaka 569-1125, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Ohta","sequence":"additional","affiliation":[{"name":"Japan Tobacco Inc., Central Pharmaceutical Research Institute, 1\u20131 Murasaki-cho, Takatsuki, Osaka 569-1125, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiro","family":"Miyajima","sequence":"additional","affiliation":[{"name":"Japan Tobacco Inc., Central Pharmaceutical Research Institute, 1\u20131 Murasaki-cho, Takatsuki, Osaka 569-1125, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Kemmochi","sequence":"additional","affiliation":[{"name":"Japan Tobacco Inc., Central Pharmaceutical Research Institute, 1\u20131 Murasaki-cho, Takatsuki, Osaka 569-1125, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Sasase","sequence":"additional","affiliation":[{"name":"Japan Tobacco Inc., Central Pharmaceutical Research Institute, 1\u20131 Murasaki-cho, Takatsuki, Osaka 569-1125, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Tong","sequence":"additional","affiliation":[{"name":"Laboratory of Animal Genetics, Graduate School of Science and Technology, Niigata University, Nishi-ku, Niigata 950-2181, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Shinohara","sequence":"additional","affiliation":[{"name":"CLEA Japan Inc., Planning and Development Section, 1\u20132\u20137 Higashiyama, Meguro-ku, Tokyo 153-8533, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Yamada","sequence":"additional","affiliation":[{"name":"Laboratory of Animal Genetics, Graduate School of Science and Technology, Niigata University, Nishi-ku, Niigata 950-2181, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"439","reference":[{"key":"1","unstructured":"1. Abdulameer S.A., Sulaiman S.A., Hassali M.A., Subramaniam K., and Sahib M.N. 2012. Osteoporosis and type 2 diabetes mellitus: what do we know, and what we can do? <i>Patient Prefer Adherence<\/i>. 6: 435\u2013448."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Barbieri R.L., Makris A., Randall R.W., Daniels G., Kistner R.W., and Ryan K.J. 1986. Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. <i>J. Clin. Endocrinol. Metab<\/i>. 62: 904\u2013910.","DOI":"10.1210\/jcem-62-5-904"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Bonner-Weir S., Li W.C., Ouziel-Yahalom L., Guo L., Weir G.C., and Sharma A. 2010. Beta-cell growth and regeneration: replication is only part of the story. <i>Diabetes<\/i> 59: 2340\u20132348.","DOI":"10.2337\/db10-0084"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Butler A.E., Janson J., Soeller W.C., and Butler P.C. 2003. Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid. <i>Diabetes<\/i> 52: 2304\u20132314.","DOI":"10.2337\/diabetes.52.9.2304"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Calcutt N.A., Cooper M.E., Kern T.S., and Schmidt A.M. 2009. Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials. <i>Nat. Rev. Drug Discov<\/i>. 8: 417\u2013429.","DOI":"10.1038\/nrd2476"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Cameron N.E. and Cotter M.A. 1992. Impaired contraction and relaxation in aorta from streptozotocin-diabetic rats: role of polyol pathway. <i>Diabetologia<\/i> 35: 1011\u20131019.","DOI":"10.1007\/BF02221675"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Chander P.N., Gealekman O., Brodsky S.V., Elitok S., Tojo A., Crabtree M., Gross S.S., and Goligorsky M.S. 2004. Nephropathy in Zucker diabetic fat rat is associated with oxidative and nitrosative stress: prevention by chronic therapy with a peroxynitrite scavenger ebselen. <i>J. Am. Soc. Nephrol<\/i>. 15: 2391\u20132403.","DOI":"10.1097\/01.ASN.0000135971.88164.2C"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Charlton H.M. 1984. Mouse mutants as models in endocrine research. <i>Q J Exp Physiol<\/i>. 69: 655\u2013676.","DOI":"10.1113\/expphysiol.1984.sp002858"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Cooper C. and Melton L.J. 1992. Epidemiology of osteoporosis. <i>Trends Endocrinol. Metab<\/i>. 3: 224\u2013229.","DOI":"10.1016\/1043-2760(92)90032-V"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Dandona P. and Dhindsa S. 2011. Update: Hypogonadotropic hypogonadism in type 2 diabetes and obesity. <i>J Clin Endocrinol Metab<\/i>. 96: 2643\u20132651.","DOI":"10.1210\/jc.2010-2724"},{"key":"11","unstructured":"11. Danis R.P. and Yang Y. 1993. Microvascular retinopathy in the Zucker diabetic fatty rat. <i>Invest. Ophthalmol. Vis. Sci<\/i>. 34: 2367\u20132371."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. DeFronzo R.A. and Abdul-Ghani M. 2011. Type 2 diabetes can be prevented with early pharmacological intervention. <i>Diabetes Care.<\/i> 34:(Suppl 2): S202\u2013S209.","DOI":"10.2337\/dc11-s221"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Dhindsa S., Prabhakar S., Sethi M., Bandyopadhyay A., Chaudhuri A., and Dandona P. 2004. Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. <i>J. Clin. Endocrinol. Metab<\/i>. 89: 5462\u20135468.","DOI":"10.1210\/jc.2004-0804"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Diabetic Retinopathy Study Research Group.1979. Four risk factors for severe visual loss in diabetic retinopathy. The third report from the Diabetic Retinopathy Study. The Diabetic Retinopathy Study Research Group. <i>Arch. Ophthalmol<\/i>. 97: 654\u2013655.","DOI":"10.1001\/archopht.1979.01020010310003"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Early Treatment Diabetic Retinopathy Study Research Group.1991. Grading diabetic retinopathy from stereoscopic color fundus photographs\u2013an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. <i>Ophthalmology<\/i> 98: 786\u2013806.","DOI":"10.1016\/S0161-6420(13)38012-9"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Felson D.T., Zhang Y., Hannan M.T., and Anderson J.J. 1993. Effects of weight and body mass index on bone mineral density in men and women: the Framingham study. <i>J. Bone Miner. Res<\/i>. 8: 567\u2013573.","DOI":"10.1002\/jbmr.5650080507"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Fujita Y., Kojima H., Hidaka H., Fujimiya M., Kashiwagi A., and Kikkawa R. 1998. Increased intestinal glucose absorption and postprandial hyperglycaemia at the early step of glucose intolerance in Otsuka Long-Evans Tokushima Fatty rats. <i>Diabetologia<\/i> 41: 1459\u20131466.","DOI":"10.1007\/s001250051092"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Garcia M.M., Fandel T.M., Lin G., Shindel A.W., Banie L., Lin C.S., and Lue T.F. 2010. Treatment of erectile dysfunction in the obese type 2 diabetic ZDF rat with adipose tissue-derived stem cells. <i>J. Sex Med<\/i>. 7: 89\u201398.","DOI":"10.1111\/j.1743-6109.2009.01541.x"},{"key":"19","unstructured":"19. Greene D.A., Sima A.A., Stevens M.J., Feldman E.L., and Lattimer S.A. 1992. Complications: neuropathy, pathogenetic considerations. <i>Diabetes Care<\/i> 15: 1902\u20131925."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Hadjidakis D.J., Mylonakis A.M., Sfakianakis M.E., Raptis A.E., and Raptis S.A. 2005. Diabetes and premature menopause: is their co-existence detrimental to the skeleton? <i>Eur. J. Endocrinol<\/i>. 152: 437\u2013442.","DOI":"10.1530\/eje.1.01853"},{"key":"21","unstructured":"21. Haffner S.M. 2000. Sex hormones, obesity, fat distribution, type 2 diabetes and insulin resistance: epidemiological and clinical correlation. <i>Int. J. Obes. Relat. Metab. Disord<\/i>. 24:(Suppl 2): S56\u2013S58."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Hall J.E., Kuo J.J., da Silva A.A., de Paula R.B., Liu J., and Tallam L. 2003. Obesity-associated hypertension and kidney disease. <i>Curr. Opin. Nephrol. Hypertens<\/i>. 12: 195\u2013200.","DOI":"10.1097\/00041552-200303000-00011"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Hamann C., Goettsch C., Mettelsiefen J., Henkenjohann V., Rauner M., Hempel U., Bernhardt R., Fratzl-Zelman N., Roschger P., Rammelt S., Gunther K.P., and Hofbauer L.C. 2011. Delayed bone regeneration and low bone mass in a rat model of insulin-resistant type 2 diabetes mellitus is due to impaired osteoblast function. <i>Am. J. Physiol. Endocrinol. Metab<\/i>. 301: E1220\u2013E1228.","DOI":"10.1152\/ajpendo.00378.2011"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Hayek A. and Woodside W. 1979. Correlation between morphology and function in isolated islets of the Zucker rat. <i>Diabetes<\/i> 28: 565\u2013569.","DOI":"10.2337\/diabetes.28.6.565"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Hoshi S., Shu Y., Yoshida F., Inagaki T., Sonoda J., Watanabe T., Nomoto K., and Nagata M. 2002. Podocyte injury promotes progressive nephropathy in zucker diabetic fatty rats. <i>Lab. Invest<\/i>. 82: 25\u201335.","DOI":"10.1038\/labinvest.3780392"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Ikeda H., Shino A., Matsuo T., Iwatsuka H., and Suzuoki Z. 1981. A new genetically obese-hyperglycemic rat (Wistar fatty). <i>Diabetes<\/i> 30: 1045\u20131050.","DOI":"10.2337\/diabetes.30.12.1045"},{"key":"27","unstructured":"27. Inaba N., Nakamura S., Hirao T., Ryumon N., Chiba K., Miyajima K., and Ohta T. 2012. Basic study on reproductive science in Spontaneously Diabetic Torii-<i>Leprfa<\/i> (SDT-<i>fa\/fa<\/i>) female rat. <i>J. Exp. Anim. Technol<\/i>. 47: 3\u201310."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Ishii Y., Maki M., Yamamoto H., Sasase T., Kakutani M., and Ohta T. 2010. Evaluation of blood pressure in Spontaneously Diabetic Torii-Lepr(fa) rats. <i>Exp. Anim<\/i>. 59: 525\u2013529.","DOI":"10.1538\/expanim.59.525"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Ishii Y., Maki M., Yamamoto H., Sasase T., Kakutani M., and Ohta T. 2011. Blood pressure characteristics of female spontaneously diabetic Torii-Lepr(fa) rats. <i>J. Vet. Med. Sci<\/i>. 73: 501\u2013505.","DOI":"10.1292\/jvms.10-0453"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Ishii Y., Ohta T., Sasase T., Morinag H., Miyajima K., and Kakutani M. 2011. Effects of food restriction on pancreatic islets in Spontaneously Diabetic Torii fatty rats. <i>J. Vet. Med. Sci<\/i>. 73: 169\u2013175.","DOI":"10.1292\/jvms.10-0283"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Ishii Y., Ohta T., Sasase T., Morinaga H., Ueda N., Hata T., Kakutani M., Miyajima K., Katsuda Y., Masuyama T., Shinohara M., and Matsushita M. 2010. Pathophysiological analysis of female Spontaneously Diabetic Torii fatty rats. <i>Exp. Anim<\/i>. 59: 73\u201384.","DOI":"10.1538\/expanim.59.73"},{"key":"32","unstructured":"32. Kanazawa M., Tanaka A., Nomoto S., Shirabe S., Hukuda G., Arai K., Notoya Y., Hayashi T., Komeda K., and Kanazawa Y. 1997. Alterations of insulin and glucagon secretion from the perfused pancreas before, at the onset and after the development of diabetes in male Otsuka Long-Evans Tokushima Fatty (OLETF) rats. <i>Diabetes Res. Clin. Pract<\/i>. 38: 161\u2013167."},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Kapoor D., Aldred H., Clark S., Channer K.S., and Jones T.H. 2007. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity. <i>Diabetes Care<\/i> 30: 911\u2013917.","DOI":"10.2337\/dc06-1426"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Karaca M., Castel J., Tourrel-Cuzin C., Brun M., Geant A., Dubois M., Catesson S., Rodriguez M., Luquet S., Cattan P., Lockhart B., Lang J., Ktorza A., Magnan C., and Kargar C. 2009. Exploring functional beta-cell heterogeneity in vivo using PSA-NCAM as a specific marker. <i>PLoS ONE<\/i>. 4: e5555.","DOI":"10.1371\/journal.pone.0005555"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Kawano K., Hirashima T., Mori S., and Natori T. 1994. OLETF (Otsuka Long-Evans Tokushima Fatty) rat: a new NIDDM rat strain. <i>Diabetes Res Clin Pract<\/i>. 24:(Suppl): S317\u2013S320.","DOI":"10.1016\/0168-8227(94)90269-0"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Kawano K., Hirashima T., Mori S., Saitoh Y., Kurosumi M., and Natori T. 1992. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. <i>Diabetes<\/i> 41: 1422\u20131428.","DOI":"10.2337\/diab.41.11.1422"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Kawano K., Mori S., Hirashima T., Man Z.W., and Natori T. 1999. Examination of the pathogenesis of diabetic nephropathy in OLETF rats. <i>J. Vet. Med. Sci<\/i>. 61: 1219\u20131228.","DOI":"10.1292\/jvms.61.1219"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Kemmochi Y., Fukui K., Maki M., Kimura S., Ishii Y., Sasase T., Miyajima K., and Ohta T. 2013. Metabolic disorders and diabetic complications in Spontaneously Diabetic Torii Lepr (fa) rat: a new obese type 2 diabetic model. <i>J. Diabetes. Res<\/i>. 2013: 948257.","DOI":"10.1155\/2013\/948257"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Kim J., Kim C.S., Sohn E., Kim H., Jeong I.H., and Kim J.S. 2011. KIOM-79 prevents lens epithelial cell apoptosis and lens opacification in Zucker diabetic fatty rats. <i>Evid. Based Complement. Alternat. Med<\/i>. 2011: 717921.","DOI":"10.1155\/2011\/717921"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Kimura S., Sasase T., Ohta T., and Matsushita M. 2011. Effects of ovariectomy on bone metabolism and bone mineral density in spontaneously diabetic Torii-Lepr(fa) rats. <i>J. Vet. Med. Sci<\/i>. 73: 1025\u20131029.","DOI":"10.1292\/jvms.11-0064"},{"key":"41","unstructured":"41. Kimura S., Sasase T., Ohta T., Sato E., and Matsushita M. 2012. Characteristics of bone turnover, bone mass and bone strength in Spontaneously Diabetic Torii-Lepr fa rats. <i>J. Bone. Miner. Metab<\/i>. 30: 312\u2013320."},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Klein B.E. 2007. Overview of epidemiologic studies of diabetic retinopathy. <i>Ophthalmic Epidemiol<\/i>. 14: 179\u2013183.","DOI":"10.1080\/09286580701396720"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Komaki K., Ohno Y., and Aoki N. 2005. Gonadal hormones and gonadal function in type 2 diabetes model OLETF (Otsuka Long Evans Tokushima Fatty) rats. <i>Endocr. J<\/i>. 52: 345\u2013351.","DOI":"10.1507\/endocrj.52.345"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Kubo E., Maekawa K., Tanimoto T., Fujisawa S., and Akagi Y. 2001. Biochemical and morphological changes during development of sugar cataract in Otsuka Long-Evans Tokushima fatty (OLETF) rat. <i>Exp. Eye. Res<\/i>. 73: 375\u2013381.","DOI":"10.1006\/exer.2001.1046"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Kyselova Z., Stefek M., and Bauer V. 2004. Pharmacological prevention of diabetic cataract. <i>J. Diabetes Complications<\/i> 18: 129\u2013140.","DOI":"10.1016\/S1056-8727(03)00009-6"},{"key":"46","unstructured":"46. Laaksonen D.E., Niskanen L., Punnonen K., Nyyssonen K., Tuomainen T.P., Salonen R., Rauramaa R., and Salonen J.T. 2003. Sex hormones, inflammation and the metabolic syndrome: a population-based study. <i>Eur. J. Endocrinol<\/i>. 149: 601\u2013608."},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Liang F. and Koya D. 2010. Acupuncture: is it effective for treatment of insulin resistance? <i>Diabetes Obes. Metab<\/i>. 12: 555\u2013569.","DOI":"10.1111\/j.1463-1326.2009.01192.x"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Lu Z.Y., Bhutto I.A., and Amemiya T. 2003. Retinal changes in Otsuka long-evans Tokushima Fatty rats (spontaneously diabetic rat)\u2013possibility of a new experimental model for diabetic retinopathy. <i>Jpn. J. Ophthalmol<\/i>. 47: 28\u201335.","DOI":"10.1016\/S0021-5155(02)00631-7"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Masuyama T., Katsuda Y., and Shinohara M. 2005. A novel model of obesity-related diabetes: introgression of the Lepr(fa) allele of the Zucker fatty rat into nonobese Spontaneously Diabetic Torii (SDT) rats. <i>Exp. Anim<\/i>. 54: 13\u201320.","DOI":"10.1538\/expanim.54.13"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Masuyama T., Komeda K., Hara A., Noda M., Shinohara M., Oikawa T., Kanazawa Y., and Taniguchi K. 2004. Chronological characterization of diabetes development in male Spontaneously Diabetic Torii rats. <i>Biochem. Biophys. Res Commun<\/i>. 314: 870\u2013877.","DOI":"10.1016\/j.bbrc.2003.12.180"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Matsui H., Suzuki M., Tsukuda R., Iida K., Miyasaka M., and Ikeda H. 1996. Expression of ICAM-1 on glomeruli is associated with progression of diabetic nephropathy in a genetically obese diabetic rat, Wistar fatty. <i>Diabetes Res. Clin. Pract<\/i>. 32: 1\u20139.","DOI":"10.1016\/0168-8227(96)01209-0"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Matsui K., Ohta T., Oda T., Sasase T., Ueda N., Miyajima K., Masuyama T., Shinohara M., and Matsushita M. 2008. Diabetes-associated complications in Spontaneously Diabetic Torii fatty rats. <i>Exp. Anim<\/i>. 57: 111\u2013121.","DOI":"10.1538\/expanim.57.111"},{"key":"53","unstructured":"53. Matsuura T., Yamagishi S., Kodama Y., Shibata R., Ueda S., and Narama I. 2005. Otsuka Long-Evans Tokushima fatty (OLETF) rat is not a suitable animal model for the study of angiopathic diabetic retinopathy. <i>Int. J. Tissue React<\/i>. 27: 59\u201362."},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Melton L.J.., Atkinson E.J., O\u2019Fallon W.M., Wahner H.W., and Riggs B.L. 1993. Long-term fracture prediction by bone mineral assessed at different skeletal sites. <i>J. Bone Miner. Res<\/i>. 8: 1227\u20131233.","DOI":"10.1002\/jbmr.5650081010"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Miyamura N., Bhutto I.A., and Amemiya T. 1999. Retinal capillary changes in Otsuka Long-Evans Tokushima fatty rats (spontaneously diabetic strain). Electron-microscopic study. <i>Ophthalmic. Res<\/i>. 31: 358\u2013366.","DOI":"10.1159\/000055559"},{"key":"56","unstructured":"56. Moran L.J., Misso M.L., Wild R.A., and Norman R.J. 2010. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. <i>Hum. Reprod. Update<\/i> 16: 347\u2013363."},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Morinaga H., Ohta T., Matsui K., Sasase T., Fukuda S., Ito M., Ueda M., Ishii Y., Miyajima K., and Matsushita M. 2009. Effect of food restriction on adipose tissue in spontaneously diabetic Torii fatty rats. <i>Exp. Diabetes Res<\/i>. 2009: 715057.","DOI":"10.1155\/2009\/715057"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Nakamura J., Del Monte M.A., Shewach D., Lattimer S.A., and Greene D.A. 1992. Inhibition of phosphatidylinositol synthase by glucose in human retinal pigment epithelial cells. <i>Am. J. Physiol<\/i>. 262: E417\u2013E426.","DOI":"10.1152\/ajpendo.1992.262.4.E417"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Nakamura J., Hamada Y., Sakakibara F., Hara T., Wakao T., Mori K., Nakashima E., Naruse K., Kamijo M., Koh N., and Hotta N. 2001. Physiological and morphometric analyses of neuropathy in sucrose-fed OLETF rats. <i>Diabetes Res. Clin. Pract<\/i>. 51: 9\u201320.","DOI":"10.1016\/S0168-8227(00)00205-9"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. Nakamura J., Koh N., Sakakibara F., Hamada Y., Wakao T., Sasaki H., Mori K., Nakashima E., Naruse K., and Hotta N. 1997. Diabetic neuropathy in sucrose-fed Otsuka Long-Evans Tokushima fatty rats: effect of an aldose reductase inhibitor, TAT. <i>Life Sci<\/i>. 60: 1847\u20131857.","DOI":"10.1016\/S0024-3205(97)00145-8"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61. Nevitt M.C., Johnell O., Black D.M., Ensrud K., Genant H.K., and Cummings S.R. 1994. Bone mineral density predicts non-spine fractures in very elderly women. Study of Osteoporotic Fractures Research Group. <i>Osteoporos. Int<\/i>. 4: 325\u2013331.","DOI":"10.1007\/BF01622192"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62. New S.A. 1999. Bone health: the role of micronutrients. <i>Br Med Bull<\/i>. 55: 619\u2013633.","DOI":"10.1258\/0007142991902501"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63. Norman R.J., Masters L., Milner C.R., Wang J.X., and Davies M.J. 2001. Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome. <i>Hum. Reprod<\/i>. 16: 1995\u20131998.","DOI":"10.1093\/humrep\/16.9.1995"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64. Okada M., Takemura T., Yanagida H., and Yoshioka K. 2002. Response of mesangial cells to low-density lipoprotein and angiotensin II in diabetic (OLETF) rats. <i>Kidney Int<\/i>. 61: 113\u2013124.","DOI":"10.1046\/j.1523-1755.2002.00107.x"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65. Oltman C.L., Coppey L.J., Gellett J.S., Davidson E.P., Lund D.D., and Yorek M.A. 2005. Progression of vascular and neural dysfunction in sciatic nerves of Zucker diabetic fatty and Zucker rats. <i>Am. J. Physiol. Endocrinol. Metab<\/i>. 289: E113\u2013E122.","DOI":"10.1152\/ajpendo.00594.2004"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66. Perl S., Kushner J.A., Buchholz B.A., Meeker A.K., Stein G.M., Hsieh M., Kirby M., Pechhold S., Liu E.H., Harlan D.M., and Tisdale J.F. 2010. Significant human beta-cell turnover is limited to the first three decades of life as determined by in vivo thymidine analog incorporation and radiocarbon dating. <i>J. Clin. Endocrinol. Metab<\/i>. 95: E234\u2013E239.","DOI":"10.1210\/jc.2010-0932"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67. Petersen J., Ross J., and Rabkin R. 1988. Effect of insulin therapy on established diabetic nephropathy in rats. <i>Diabetes<\/i> 37: 1346\u20131350.","DOI":"10.2337\/diab.37.10.1346"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68. Pfeifer M.A., Halter J.B., and Porte D. Jr. 1981. Insulin secretion in diabetes mellitus. <i>Am. J. Med<\/i>. 70: 579\u2013588.","DOI":"10.1016\/0002-9343(81)90579-9"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69. Piper M.L., Unger E.K., Myers M.G. Jr., and Xu A.W. 2008. Specific physiological roles for signal transducer and activator of transcription 3 in leptin receptor-expressing neurons. <i>Mol. Endocrinol<\/i>. 22: 751\u2013759.","DOI":"10.1210\/me.2007-0389"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70. Plymate S.R., Matej L.A., Jones R.E., and Friedl K.E. 1988. Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. <i>J. Clin. Endocrinol. Metab<\/i>. 67: 460\u2013464.","DOI":"10.1210\/jcem-67-3-460"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71. Porta M., Maldari P., and Mazzaglia F. 2011. New approaches to the treatment of diabetic retinopathy. <i>Diabetes Obes. Metab<\/i>. 13: 784\u2013790.","DOI":"10.1111\/j.1463-1326.2011.01415.x"},{"key":"72","unstructured":"72. Rand L.I., Prud\u2019homme G.J., Ederer F., and Canner P.L. 1985. Factors influencing the development of visual loss in advanced diabetic retinopathy. Diabetic Retinopathy Study (DRS) Report No. 10. <i>Invest Ophthalmol. Vis. Sci<\/i>. 26: 983\u2013991."},{"key":"73","doi-asserted-by":"crossref","unstructured":"73. Ritz E. and Stefanski A. 1996. Diabetic nephropathy in type II diabetes. <i>Am. J. Kidney Dis<\/i>. 27: 167\u2013194.","DOI":"10.1016\/S0272-6386(96)90538-7"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74. Schmidt R.E., Dorsey D.A., Beaudet L.N., and Peterson R.G. 2003. Analysis of the Zucker Diabetic Fatty (ZDF) type 2 diabetic rat model suggests a neurotrophic role for insulin\/IGF-I in diabetic autonomic neuropathy. <i>Am. J. Pathol<\/i>. 163: 21\u201328.","DOI":"10.1016\/S0002-9440(10)63626-7"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75. Segawa Y., Shirao Y., Yamagishi S., Higashide T., Kobayashi M., Katsuno K., Iyobe A., Harada H., Sato F., Miyata H., Asai H., Nishimura A., Takahira M., Souno T., Segawa Y., Maeda K., Shima K., Mizuno A., Yamamoto H., and Kawasaki K. 1998. Upregulation of retinal vascular endothelial growth factor mRNAs in spontaneously diabetic rats without ophthalmoscopic retinopathy. A possible participation of advanced glycation end products in the development of the early phase of diabetic retinopathy. <i>Ophthalmic. Res<\/i>. 30: 333\u2013339.","DOI":"10.1159\/000055493"},{"key":"76","unstructured":"76. Shimoshige Y., Ikuma K., Yamamoto T., Takakura S., Kawamura I., Seki J., Mutoh S., and Goto T. 2000. The effects of zenarestat, an aldose reductase inhibitor, on peripheral neuropathy in Zucker diabetic fatty rats. <i>Metabolism<\/i> 49: 1395\u20131399."},{"key":"77","doi-asserted-by":"crossref","unstructured":"77. Shino A., Matsuo T., Iwatsuka H., and Suzuoki Z. 1973. Structural changes of pancreatic islets in genetically obese rats. <i>Diabetologia<\/i> 9: 413\u2013421.","DOI":"10.1007\/BF01239438"},{"key":"78","unstructured":"78. Sima A.A., Nathaniel V., Bril V., McEwen T.A., and Greene D.A. 1988. Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes, and demonstration of axo-glial dysjunction in human diabetic neuropathy. <i>J. Clin. Invest<\/i> 81: 349\u2013364."},{"key":"79","unstructured":"79. Stevens M.J., Dananberg J., Feldman E.L., Lattimer S.A., Kamijo M., Thomas T.P., Shindo H., Sima A.A., and Greene D.A. 1994. The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat. <i>J. Clin. Invest<\/i> 94: 853\u2013859."},{"key":"80","doi-asserted-by":"crossref","unstructured":"80. Taylor S.I., Accili D., and Imai Y. 1994. Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM? <i>Diabetes<\/i> 43: 735\u2013740.","DOI":"10.2337\/diab.43.6.735"},{"key":"81","doi-asserted-by":"crossref","unstructured":"81. Tesfamariam B., Palacino J.J., Weisbrod R.M., and Cohen R.A. 1993. Aldose reductase inhibition restores endothelial cell function in diabetic rabbit aorta. <i>J. Cardiovasc. Pharmacol<\/i> 21: 205\u2013211.","DOI":"10.1097\/00005344-199302000-00004"},{"key":"82","unstructured":"82. Thomas T., Burguera B., Melton L.J.., Atkinson E.J., O\u2019Fallon W.M., Riggs B.L., and Khosla S. 2001. Role of serum leptin, insulin, and estrogen levels as potential mediators of the relationship between fat mass and bone mineral density in men versus women. <i>Bone<\/i> 29: 114\u2013120."},{"key":"83","doi-asserted-by":"crossref","unstructured":"83. Thomas T.P., Feldman E.L., Nakamura J., Kato K., Lien M., Stevens M.J., and Greene D.A. 1993. Ambient glucose and aldose reductase-induced myo-inositol depletion modulate basal and carbachol-stimulated inositol phospholipid metabolism and diacylglycerol accumulation in human retinal pigment epithelial cells in culture. <i>Proc. Natl. Acad. Sci. USA<\/i>. 90: 9712\u20139716.","DOI":"10.1073\/pnas.90.20.9712"},{"key":"84","doi-asserted-by":"crossref","unstructured":"84. Tokuyama Y., Sturis J., DePaoli A.M., Takeda J., Stoffel M., Tang J., Sun X., Polonsky K.S., and Bell G.I. 1995. Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat. <i>Diabetes<\/i> 44: 1447\u20131457.","DOI":"10.2337\/diabetes.44.12.1447"},{"key":"85","doi-asserted-by":"crossref","unstructured":"85. Tomlinson D.R., Willars G.B., and Carrington A.L. 1992. Aldose reductase inhibitors and diabetic complications. <i>Pharmacol. Ther<\/i>. 54: 151\u2013194.","DOI":"10.1016\/0163-7258(92)90031-T"},{"key":"86","doi-asserted-by":"crossref","unstructured":"86. Varkonyi T. and Kempler P. 2008. Diabetic neuropathy: new strategies for treatment. <i>Diabetes Obes. Metab<\/i>. 10: 99\u2013108.","DOI":"10.1111\/j.1463-1326.2007.00741.x"},{"key":"87","doi-asserted-by":"crossref","unstructured":"87. Velasquez M.T., Kimmel P.L., and Michaelis O.E.t. 1990. Animal models of spontaneous diabetic kidney disease. <i>FASEB J<\/i>. 4: 2850\u20132859.","DOI":"10.1096\/fasebj.4.11.2199283"},{"key":"88","doi-asserted-by":"crossref","unstructured":"88. Vora J.P., Zimsen S.M., Houghton D.C., and Anderson S. 1996. Evolution of metabolic and renal changes in the ZDF\/Drt-fa rat model of type II diabetes. <i>J. Am. Soc. Nephrol<\/i>. 7: 113\u2013117.","DOI":"10.1681\/ASN.V71113"},{"key":"89","doi-asserted-by":"crossref","unstructured":"89. Wakasugi M., Wakao R., Tawata M., Gan N., Koizumi K., and Onaya T. 1993. Bone mineral density measured by dual energy x-ray absorptiometry in patients with non-insulin-dependent diabetes mellitus. <i>Bone<\/i> 14: 29\u201333.","DOI":"10.1016\/8756-3282(93)90252-6"},{"key":"90","doi-asserted-by":"crossref","unstructured":"90. Yagihashi S. and Matsunaga M. 1979. Ultrastructural pathology of peripheral nerves in patients with diabetic neuropathy. <i>Tohoku J. Exp. Med<\/i>. 129: 357\u2013366.","DOI":"10.1620\/tjem.129.357"},{"key":"91","doi-asserted-by":"crossref","unstructured":"91. Yamagishi S., Nakamura K., and Inoue H. 2005. Possible participation of advanced glycation end products in the pathogenesis of osteoporosis in diabetic patients. <i>Med Hypotheses<\/i> 65: 1013\u20131015.","DOI":"10.1016\/j.mehy.2005.07.017"},{"key":"92","doi-asserted-by":"crossref","unstructured":"92. Yamaguchi T., Sasase T., Mera Y., Tomimoto D., Tadaki H., Kemmochi Y., Ohta T., Sato E., and Matsushita M. 2012. Diabetic Peripheral Neuropathy in Spontaneously Diabetic Torii-Lepr(fa) (SDT Fatty) Rats. <i>J. Vet. Med. Sci<\/i>. 74: 1669\u20131673.","DOI":"10.1292\/jvms.12-0149"},{"key":"93","doi-asserted-by":"crossref","unstructured":"93. Yang Y.S., Danis R.P., Peterson R.G., Dolan P.L., and Wu Y.Q. 2000. Acarbose partially inhibits microvascular retinopathy in the Zucker Diabetic Fatty rat (ZDF\/Gmi-fa). <i>J. Ocul. Pharmacol. Ther<\/i>. 16: 471\u2013479.","DOI":"10.1089\/jop.2000.16.471"},{"key":"94","doi-asserted-by":"crossref","unstructured":"94. Yau J.W., Rogers S.L., Kawasaki R., Lamoureux E.L., Kowalski J.W., Bek T., Chen S.J., Dekker J.M., Fletcher A., Grauslund J., Haffner S., Hamman R.F., Ikram M.K., Kayama T., Klein B.E., Klein R., Krishnaiah S., Mayurasakorn K., O\u2019Hare J.P., Orchard T.J., Porta M., Rema M., Roy M.S., Sharma T., Shaw J., Taylor H., Tielsch J.M., Varma R., Wang J.J., Wang N., West S., Xu L., Yasuda M., Zhang X., Mitchell P., and Wong T.Y. 2012. Global prevalence and major risk factors of diabetic retinopathy. <i>Diabetes Care<\/i> 35: 556\u2013564.","DOI":"10.2337\/dc11-1909"},{"key":"95","unstructured":"95. Zhu X. and Eichberg J. 1990. 1,2-diacylglycerol content and its arachidonyl-containing molecular species are reduced in sciatic nerve from streptozotocin-induced diabetic rats. <i>J. Neurochem<\/i>. 55: 1087\u20131090."}],"container-title":["Experimental Animals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/expanim\/63\/2\/63_13-0080\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T05:52:31Z","timestamp":1716702751000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/expanim\/63\/2\/63_13-0080\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":95,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1538\/expanim.63.121","relation":{},"ISSN":["1341-1357","1881-7122"],"issn-type":[{"value":"1341-1357","type":"print"},{"value":"1881-7122","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}